Projects that used resources, services, and/or funding administered by the University of Maryland, Baltimore (UMB), Institute for Clinical and Translational Research (ICTR) are required to acknowledge the UMB ICTR in publications, presentations, patents, and grant applications. This includes projects supported by NIH National Center for Advancing Translational Science (NCATS) Clinical Translational Science Awards (CTSAs) UL1, TL1, KL2, UM1, T32, K12) 

Please use the correct citation language below to cite the appropriate Internal support or NIH NCATS CTSA Award in your publication, presentation, press release, grant applications. If you are unsure how to cite, please reach out to UMB ICTR Navigator.   

 

ICTR Internally Supported Services and Funding Acknowledgement

INTERNALLY supported services and funding since December 2017 to current date include:  

  • Consultation resources/services provided by one or more of the ICTR’s Cores of services listed on the ICTR website under Investigator Resources. If your publication includes the ICTR Core Service consultant/provider on the authorship list, please email UMB ICTR Navigator. The publication might need to acknowledge the UL1 or UM1 CTSA project number. 
  • ICTR Funding – ICTR Voucher support and internally funded ATIP/CEnR pilot grant support 
  • Internally funded education and training programs 
    • Predoctoral Clinical Translational Research Training Grant 
    • Postdoctoral Clinical Translational Research Training Grant 
    • Mentored Career Development Award 

 Acknowledgment Language 

“This research was supported in part by the shared resources of the University of Maryland, Baltimore (UMB) Institute for Clinical & Translational Research (ICTR) through funding from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH) under award number [see below for grant #*]. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.” 

*For ICTR consultation services/resources and/or internal funding provided between 5/31/2019 and 4/30/2024, please use UL1TR003098

*For ICTR consultation services/resources and/or internal funding provided between 5/15/2024 and to the current date, please use UM1TR004926

NCATS CTSA Support Received between May 31, 2019, and April 30, 2024

“We acknowledge the support of the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UL1TR003098 and the University of Maryland, Baltimore (UMB), Institute for Clinical & Translational Research (ICTR). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the official view of UMB.”

For NCATS TL1 Predoctoral and Postdoctoral Clinical Translational Research Trainees: “The research reported in this [publication/press release] was supported by the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health under award number TL1TR003100. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.”

Acknowledgment Language 

For NCATS KL2 Scholars: “The research reported in this [publication/press release] was supported by the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health under award number KL2TR003099 The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.”

 

NCATS CTSA Support Received between May 15, 2024, to Current Date

For NCATS JHU-UMB ATIP Pilot Grants: “We acknowledge the support of the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UM1TR004926 and the University of Maryland, Baltimore (UMB), Institute for Clinical & Translational Research (ICTR). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the official view of UMB.”

For NCATS T32 Predoctoral Clinical Translational Research Trainees: “The research reported in this [publication/press release] was supported by the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health under award number T32TR004928. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.”

For NCATS T32 Postdoctoral Clinical Translational Research Trainees: "“The research reported in this [publication/press release] was supported by the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health under award number T32TR005306. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.”.”

Acknowledgment Language 

For NCATS K12 Scholars: “The research reported in this [publication/press release] was supported by the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health under award number K12TR004925. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.”

NIH Public Access Policy and Other Resources

For all NCATS‑funded faculty and trainees, please review the NIH Public Access Policy. Effective July 1, 2025, author‑accepted manuscripts resulting from the use of NCATS CTSA awards must be submitted to PubMed Central immediately upon acceptance for publication. These manuscripts must be made publicly available in PubMed Central without embargo on the Official Date of Publication.

This requirement ensures compliance with NIH’s public access mandate and supports timely dissemination of NCATS‑supported scientific findings.

When publishing a peer-reviewed paper acknowledging NIH support, the following steps are required:

  1. Add the paper’s citation to the investigator’s bibliography in My NCBI.
  2. Add the CTSA grant number to supported papers listed in My NCBI.
  3. Ensure the paper has been issued a PMCID within 3 months of publication.

The full article will not be available in PubMed until after the journal embargo period (up to 12 months), but assignment of a PMCID is not dependent on the embargo.

Instructions for Public Access Compliance

  1. Login to My NCBI.
  2. Go to My Bibliography.
  3. Add publication to My Bibliography page by clicking +Add citationsFrom PubMed.
  4. Search with the PMID number or author name, then click Add to My Bibliography.
  5. Add NIH award number in the Public Access Compliance box. The box will show the non-compliance status unless the submission was started by the journal (will have a NIHMS number).
  6. Edit status in Public Access Compliance box based on NIH funding, peer-review, direct journal submissions to PMC, and exemptions (e.g., non-peer reviewed).
  7. For peer-reviewed publications with NIH funding that the journal has not submitted to PMC, click Begin submission in the NIHMS.
  8. Follow the step-by-step instructions in NIHMS. You will need the last author-submitted Word document (accepted version), not the journal's formatted PDF.

NIH Manuscript Submission System (NIHMS)

NIHMS supports the deposit of manuscripts into PubMed Central (PMC) as required by the public access policies of the NIH and other participating funders.

Sign in - NIHMS

ICTR Supporting Documents for Grant Applications

For UMB investigators needing an ICTR Letter of Support and/or the most current ICTR Resources/Environment document, please use the ICTR LOS Resources Environment Request Form
Please note, the link may not work if connected to a VPN. 

Other Campus Data Resources

Campus Faculty and Student Statistics


The University of Maryland, Baltimore collaborates with Johns Hopkins University for the prestigious National Institutes of Health (NIH) Clinical and Translational Science Award (CTSA).